2L
MED icon

22NW LP’s Medifast MED Stock Holding History

22NW LP’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-89,596
Closed -$9.29M – 16
2023
Q1 		$9.29M Hold
89,596
– – 5.71% 8
2022
Q4 		$10.3M Hold
89,596
– – 5.58% 8
2022
Q3 		$9.71M Buy
89,596
+23,700
+36% +$3.4M 5.49% 8
2022
Q2 		$11.9M Hold
65,896
– – 6.31% 9
2022
Q1 		$11.3M Hold
65,896
– – 4.09% 12
2021
Q4 		$13.8M Buy
65,896
+12,172
+23% +$2.52M 4.27% 9
2021
Q3 		$10.3M Hold
53,724
– – 3.08% 12
2021
Q2 		$15.2M Hold
53,724
– – 4.09% 7
2021
Q1 		$11.4M Hold
53,724
– – 3.51% 9
2020
Q4 		$10.5M Hold
53,724
– – 3.78% 8
2020
Q3 		$8.84M Hold
53,724
– – 4.48% 7
2020
Q2 		$7.46M Hold
53,724
– – 4.04% 5
2020
Q1 		$3.36M Buy
53,724
+37,763
+237% +$3.44M 2.61% 9
2019
Q4 		$1.75M Buy
+15,961
New +$1.54M 1.99% 15

Other funds holding MED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

22NW LP's MED Position: Q2 2023 in Review

22NW LP sold out of Medifast (MED) in Q2 2023, closing a stake of 89,596 shares — an estimated $9.29M sold.

22NW LP first reported a position in MED in Q4 2019 and held it in 14 quarters. The position peaked at $15.2M in Q2 2021. 236 funds tracked by Wall St. Rank hold MED as of Q2 2023.

  • 22NW LP reported no remaining Medifast position as of Q2 2023 after selling out during the quarter.
  • 22NW LP sold 89,596 Medifast shares in Q2 2023, an estimated $9.29M.
  • 22NW LP first reported a position in Medifast in Q4 2019 and held it in 14 quarters.
  • 22NW LP's Medifast position peaked at $15.2M in Q2 2021.
  • 236 funds tracked by Wall St. Rank held Medifast as of Q2 2023.

Based on 22NW LP's 13F filing for Q2 2023, filed 14 Aug 2023.